Skip to content
Search AI Powered

Latest Stories

PDA urges employers to allow exam-facing prov-reg pharmacists some flexibility

The PDA has urged pharmacy employers to remain flexible and supportive towards provisionally registered pharmacists as they are scheduled to face exams in March amid growing workload pressure.

The Pharmacists Defence Association’s (PDA) latest call follows complaints from the provisionally registered members that they are facing contractual issues and some are not being able get leave and a flexible atmosphere to prepare for the tests in.


“We all want to support those provisionally registered and the pre-reg resitters, many of whom are working in other roles within pharmacy, to have the best opportunity possible to become pharmacists in these challenging times,” the PDA said in a statement.

Many of the provisionally registered pharmacists told the association that during the second wave of the virus pandemic, there is unprecedented pressure on pharmacy services and as the Covid-19 vaccine programme gains pace, there will be a tremendous workload for pharmacists.

“Some provisionally registered members are reporting that their study and revision leave, previously agreed, is now being cancelled by their employer and they are struggling to prepare for the assessment,” the PDA noted.

Paul Day, the PDA director, said: “Many of our locum pharmacists have indicated, since the announcement of the dates of the assessment, that they are available to offer cover and employers should utilise that population. These are difficult times for everyone and the whole pharmacy community has a part to play in ensuring exam candidates can continue with their careers.”

Mark Pitt, PDA director of defence services, said: “Pharmacy is a caring profession and during these unprecedented times we must support those who will become the next generation of pharmacists and future leaders of our profession. The PDA urges employers to be flexible, act reasonably and behave responsibly towards prov-regs to empower them to make decisions about the upcoming assessment which are personally right for them.

“This vulnerable group are working and learning in incredibly stressful and pressurised working environments, balancing personal and work commitments to provide high-quality care to patients. This extraordinary situation is an opportunity for pharmacy employers to embrace the values inherent in our profession by prioritising the needs of prov-regs over the next few months.

“This will give them the best chance to pass the assessment and to more comprehensively help patients once fully registered. The PDA will continue to support members to exercise their choice and to either secure the time off for revision they need and/or to decide if they are ‘fit to sit’”.

Meanwhile, the General Pharmaceutical Council (GPhC) has made it clear to employers that there was an additional requirement on employers – provision for study time prior to the registration assessment.

The GPhC confirmed earlier this week that they expect employers to uphold their commitment to those provisionally registered, who want to sit the exam, by granting them the time off for study and revision as agreed.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less